ITV political editor, Robert Peston, reports on the matter
The report says that there will be positive news soon - perhaps tomorrow - on the initial trials of the Oxford Covid-19 vaccine that has been backed by AstraZeneca.
It is said that the vaccine is generating a kind of antibody and T-cell response that researches have hoped to see but the efficacy can only be properly established once Phase III of the programme i.e. testing in Brazil gets underway.
The first data is due to be published by in The Lancet so watch out for that before the weekend. This could be add more tailwind to risk assets once it is made official.
The ITV report can be found here.
Update: Stocks are getting a more positive nudge on the report here with the DAX now up by over 1% while US futures also got a mini-spike higher to be up ~0.8%.
